IONIS PHARMACEUTICALS, INC. 10-K 12-31-2023

Company

IONIS PHARMACEUTICALS INC

Filed

February 21, 2024

Period of Report

December 31, 2023

Accession Number

0000874015-24-000116

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →